Know Cancer

or
forgot password


N/A
N/A
N/A
Not Enrolling
Both
Sarcoidosis

Thank you

Trial Information


Inclusion Criteria:



- Eligible patients were required to have histologically proven noncaseating
epithelioid cell granuloma and at least one disease that the possibility of
coexistent malignancy could not be excluded as follows; 1) extrapulmonary lesions
mimicking malignant diseases including systemic lymphadenopathy, hepatosplenic
involvement, or other lesions, 2) multiple nodular lesions mimicking pulmonary
metastasis, 3) the occurrence of BHL in cancer patient.

Exclusion Criteria:

- The patients that PET imaging using 18F-FDG and 18F-FMT was performed before
establishment of the final diagnosis of sarcoidosis, patients undergoing treatment
for sarcoidosis before the PET study, and patient having diabetes mellitus.

Type of Study:

Observational

Study Design:

Observational Model: Defined Population, Primary Purpose: Screening, Time Perspective: Longitudinal, Time Perspective: Prospective

Principal Investigator

kyoichi kaira, MD

Investigator Role:

Principal Investigator

Investigator Affiliation:

Gunma University Graduate School of Medicine

Authority:

Japan: Institutional Review Board

Study ID:

GunmaU

NCT ID:

NCT00369980

Start Date:

September 1998

Completion Date:

August 2005

Related Keywords:

  • Sarcoidosis
  • Sarcoidosis

Name

Location